Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study

Starting soon · Not applicable

Conditions studied: Parkinson Disease

In brief

Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide, with a prevalence expected to double by 2040. The diagnosis of PD is often a shock for patients and their families, due to a lack of preparation and adequate support. Progress has been made with the establishment of Parkinson's disease expert centers (PDECs) and better-structured care pathways, but limitations remain. The needs of patients, their caregivers, and neurologists at the time of diagnosis were studied, leading to the development of a flexible, adaptable, and multidisciplinary home-based care pathway. This pathway includes multimodal communication tools (booklet and website) and can also be used by caregivers. The aim is to evaluate this pathway at the departmental level and its ability to prevent the medical, social, and psychosocial risks that complicate the care of patients newly diagnosed with PD. Thus, offering the patient, their caregiver and their neurologist a truly flexible and local care pathway built according to their needs, from the moment the disease is announced, could allow for better acceptance of the disease, an improvement in quality of life, the adoption of beneficial practices as well as a patient-caregiver therapeutic alliance with good adherence to drug and non-drug therapies.

Key facts

Study ID

NCT07578272

Run by

University Hospital, Toulouse

People needed

100

Starts

2026-09-01

Expected to finish

2028-03-31

Last updated by the study team

2026-05-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• For patients:
• Patients with newly diagnosed Parkinson's disease (< 1 month)
• Over 18 years of age
• For caregivers (if the caregiver does not wish to participate, the patient can be included):
• Primary caregiver of a patient with newly diagnosed Parkinson's disease (< 1 month)
• Over 18 years of age

You may not qualify if…

• For patients
• Institutionalized patients
• Residents of an area not covered by the intervention zone of specialized neurodegenerative disease teams
• For caregivers
• Participants who do not wish to participate

Where it is running

• Service de Neurologie Cognitive, Comportementale et Mouvement anormaux CHU de Toulouse, Hôpital Pierre Paul Riquet, 31059 Toulouse Cedex 9 — Toulouse, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.